Loading...
Loading...
Toggle sidebar
Search Ctrl + K
Filing information
Nabriva Therapeutics Plc
Filing: 10-K
Filed On: 2023-04-17
Email Link to Filing
Print Filing
Download PDF
Download all tables
Your filing highlights
Compare documents
EDGAR Index Page
Documents
10-K
10-K
EX-10.60
nbrv-20221231xex10d60.htm
EX-10.61
nbrv-20221231xex10d61.htm
EX-10.62
nbrv-20221231xex10d62.htm
EX-21.1
Subsidiaries of the registrant
EX-23.1
Consents of experts and counsel
EX-31.1
Management Certification of annual or quarter disclosure
EX-31.2
Management Certification of annual or quarter disclosure
EX-32.1
Section 1350 Certifications
EX-32.2
nbrv-20221231xex32d2.htm
0001558370-23-006062.txt
Data files
EX-101.SCH
nbrv-20221231.xsd
EX-101.CAL
nbrv-20221231_cal.xml
EX-101.DEF
nbrv-20221231_def.xml
EX-101.LAB
nbrv-20221231_lab.xml
EX-101.PRE
nbrv-20221231_pre.xml
XML
nbrv-20221231x10k_htm.xml
Free Trial
Save highlight
Link to highlight
Your browser does not support iframes.